Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament

Details for Australian Patent Application No. 2004215678 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Glombik, Heiner; Schaefer, HansLudwig; Stapper, Christian; Keil, Stefanie; Gretzke, Dirk; Wendler, Wolfgang; Goerlitzer, Jochen; Falk, Eugen

Agent Watermark

Pub. Number AU-B-2004215678

PCT Pub. Number WO2004/076401

Priority 103 08 356.1 27.02.03 DE

Filing date 19 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 11 February 2010

International Classifications

C07C 275/26 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07C 275/10 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 275/16 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 275/24 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 275/28 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 309/00 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 319/00 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 323/04 (2006.01) Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms

C07D 325/00 (2006.01) Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups

Event Publications

15 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076401 Priority application(s): WO2004/076401

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

11 February 2010 Application Accepted

  Published as AU-B-2004215678

10 June 2010 Standard Patent Sealed

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215679-CCR-3 receptor antagonists

2004215677-4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohex yloxy)-butane acid derivatives and related compounds as PPAR modulators for treating diabetes of type 2 and atherosclerosis